Background: The National Council for the Elderly estimates that 20-25% of older Irish people have a mental disorder of varying severity at some point in their lives. The rise in awareness and acceptance of Mental Health Disorders (MHD) coupled with recent pharmacological advances have led to increases in both diagnosis and prescription of medications among older people. Our study focused on the prevalence of polypharmacy in Long-Term Care (LTC) residents, particularly those with MHD and Neurological Disorders (ND). Methods: Data was collected from a randomly selected group of LTC residents. Rates of polypharmacy (>4 medicines) and excessive polypharmacy (>10 medicines) along with co-morbidities such as MHD/ND were determined from analysis of the Integrated Residential Assessment Programme (iRAP), inpatient drug Kardex and clinical notes. The results were analysed using Microsoft Excel. Result: 55 residents were included. 71% were female and 29%, male. Median age was 81. 98% were observed to have polypharmacy, with equal prevalence among male and female residents. All 76.3% residents with documented MHD and/or ND were shown to have polypharmacy. Residents without any diagnosis of MHD/ND had an average of 10 medications compared to an average of 12 in the MHD/ND group. Conclusion: Polypharmacy in those with MHD/ND was prevalent among LTC residents. Regular review of their medications is essential as polypharmacy places these older patients at a high risk of adverse effects. This can be facilitated by electronic medication recording and remote review by Geriatricians and Old Age Psychiatrists. iii13
